Table 5 Rates of antimicrobial susceptibility for the common gram-negative organisms identified
From: Bloodstream infections at a tertiary level paediatric hospital in South Africa
Acinetobacter baumanii (N = 59) | Escherichia coli (N = 92) | Klebsiella pneumoniae (N = 92) | Pseudomonas aeruginosa (N = 26) | Non-typhoidal Salmonella (N = 20) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Antimicrobial | No isolates tested | No (%) Susceptible | No isolates tested | No (%) Susceptible | No isolates tested | N (%) Susceptible | No isolates tested | N (%) Susceptible | No isolates tested | N (%) Susceptible |
Ampicillin | – | – | 91 | 9 (9.9) | 92 | – | – | – | 20 | 19 (95) |
Co-amoxyclava | – | – | 89 | 43 (48.3) | 91 | 27 (29.7) | – | – | 1 | 1 (100) |
Ceftriaxone | – | – | 90 | 59 (65.6) | 88 | 20 (22.7) | – | – | 20 | 20 (100) |
Ceftazidime | 59 | 24 (40.7) | 91 | 60 (65.9) | 91 | 20 (22) | 26 | 23 (88.5) | 1 | 1 (100) |
Ciprofloxacin | 59 | 45 (76.3) | 87 | 70 (80.5) | 85 | 52 (61.2) | 26 | 15 (57.7) | 19 | 18 (94.7) |
Piperacillin-tazobactam | 58 | 10 (17.2) | 6$ | 5 (83.3) | 49$ | 34 (69.4) | 7$ | 1 (14.3) | 1$ | 1 (100) |
Gentamicin | 59 | 27 (45.8) | 91 | 64 (70.3) | 89 | 25 (28.1) | 25 | 15 (60) | – | – |
Amikacin | 58 | 26 (44.8) | 92 | 77 (83.7) | 91 | 70 (76.9) | 26 | 16 (61.5) | – | – |
Meropenem | 56 | 26 (46.4) | 92 | 92 (100) | 92 | 92 (100) | 26 | 22 (84.6) | 20 | 20 (100) |
Imipenem | 49 | 27 (55.1) | 90 | 90 (100) | 90 | 90 (100) | 26 | 21 (80.8) | 20 | 20 (100) |
Ertapenem | 92 | 92 (100) | 91 | 91 (100) | – | – | 20 | 20 (100) | ||
Colistin | 59 | 59 (100) | 90 | 90 (100) | 89 | 89 (100) | 26 | 23 (88.5) | – | – |